Related Experiment Video
Updated: Feb 7, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Management and treatment of deep vein thrombosis in special populations
Gudula Boon1, L F Van Dam1, F A Klok1
1a Department of Thrombosis and Hemostasis , Leiden University Medical Center , Leiden , The Netherlands.
Insights
Treating venous thromboembolism (VTE), like deep vein thrombosis (DVT), presents unique challenges in special populations, including cancer patients and pregnant women, due to increased risks.
Area of Science:
- Cardiovascular Medicine
- Hematology
Background:
- Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant cardiovascular disease.
- DVT requires prompt treatment to prevent life-threatening complications, though special populations present unique therapeutic challenges.
Purpose of the Study:
- To review the complexities and current treatment strategies for DVT in specific patient groups.
- To highlight the distinct considerations for cancer-associated VTE, extensive DVT, recurrent DVT, and DVT in pregnancy.
Main Methods:
- Review of current literature and clinical trial data concerning DVT management in special populations.
- Analysis of treatment differences based on patient-specific factors like cancer, extent of thrombosis, recurrence, and pregnancy status.
Main Results:
- Cancer-associated VTE requires tailored treatment due to disease interventions and elevated bleeding risks.
- Catheter-directed thrombolysis for extensive DVT lacks a standard recommendation despite investigation.
- Diagnosing recurrent DVT and managing DVT in pregnancy involve specific complexities and risks.
Conclusions:
- DVT treatment in special populations is complicated by high thrombotic and bleeding risks.
- Individualized treatment strategies are essential for managing DVT in diverse and high-risk patient groups.
Introduction:
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most frequent cardiovascular disease besides myocardial infarction and stroke. Because DVT may cause life-threatening conditions, treatment should be started as soon as possible. This comprises certain challenges in special populations. Areas covered: In cancer-associated VTE, current treatment is different from non-cancer VTE due to disease-related interventions and higher bleeding risks. In the treatment of patients with extensive DVT, the role of catheter-directed thrombolysis has been investigated in two randomized trials, but results do not yield a recommendation for standard thrombolysis. The diagnosis of suspected recurrent DVT is especially challenging in case of ipsilateral DVT. Treatment strategies in recurrent DVT are dependent on the case and on particular risk factors. Also discussed is the therapy for DVT in pregnant women, which is more complex as a result of anticoagulants crossing the placenta. Expert commentary: DVT treatment in special populations poses special challenges due to high thrombotic and bleeding risk. This will be discussed in more detail in this review.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Special Staining Techniques
Conservation of Small Populations
What is Population Genetics?
Population Growth

